WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996006844) 4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL SUCCINATE AS ANTIVIRAL AGENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/006844    International Application No.:    PCT/GB1995/002014
Publication Date: 07.03.1996 International Filing Date: 25.08.1995
Chapter 2 Demand Filed:    30.01.1996    
IPC:
A61K 31/52 (2006.01), C07D 473/00 (2006.01)
Applicants: THE WELLCOME FOUNDATION LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB) (For All Designated States Except US).
DALUGE, Susan, Mary [US/US]; (US) (For US Only).
WILSON, Jeffrey, Douglas [US/US]; (US) (For US Only)
Inventors: DALUGE, Susan, Mary; (US).
WILSON, Jeffrey, Douglas; (US)
Agent: DAWSON, Hugh; The Wellcome Foundation Limited, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB)
Priority Data:
9417249.1 26.08.1994 GB
Title (EN) 4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL SUCCINATE AS ANTIVIRAL AGENT
(FR) UTILISATION DU SUCCINATE DE 4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)-2-CYCLOPENTENE-METHANOL COMME AGENT ANTIVIRAL
Abstract: front page image
(EN)The present invention relates to the succinate salt of (1S,4R)-cis-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol or a solvate thereof, to pharmaceutical formulations containing such a compound or pharmaceutical formulations, and to its use in medical therapy or in methods of treatment or prophylaxis of a viral infection, specifically human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infection.
(FR)La présente invention concerne le sel de succinate de (1S, 4R)-cis-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentène-1-méthanol ou un solvate de celui-ci, les préparations pharmaceutiques contenant ce composé ainsi que le champ des applications de cette substance ou des préparations pharmaceutiques dans lesquelles elle entre, notamment son utilisation thérapeutique, ou comme technique de traitement ou de prophylaxie d'une infection virale, en particulier, des infections par les virus de l'immunodéficience humaine (HIV) et de l'hépatite B (HBV).
Designated States: AM, AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)